Takeda Pharmaceutical Company Ltd. is the largest pharmaceutical company in Japan and Asia and the 18th largest in the world. Its world class, patient-focused research and development (R&D) organization is committed to innovation in oncology, gastroenterology, and central nervous system diseases as well as vaccines.
Takeda is a leader today because of a complex, thoughtful transformation of its global R&D capabilities. A carefully conceived change management program has embraced external innovation, focused resources, fostered investment in new capabilities, and attracted the best people to ensure success. This companywide effort has not only improved R&D productivity and provided sustainable growth over the long-term but also motivated employees to excel in an increasingly competitive external environment. Working with other senior leaders, Paul Graves, vice president and head, R&D network relationships and strategic communications, played a key role in initiating and managing change and re-shaping the culture of Takeda R&D to embrace new external opportunities and partnerships while increasing the company’s profile, reputation, credibility, and attractiveness as a place to work. The success of this initiative is of special interest given Takeda’s deep Japanese roots and the importance of maintaining a unique global culture.
- Reshape company culture to drive performance and innovation
- Communicate and manage change strategically in complex global organizations
- Identify external partnerships that enhance your organization’s capabilities
- Elevate employees’ experiences through new business models and opportunities